Incidence of dementia with Lewy bodies and Parkinson disease dementia.

IMPORTANCE Epidemiologic data on dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD) remain limited in the United States and worldwide. These data are essential to guide research and clinical or public health interventions. OBJECTIVE To investigate the incidence of DLB among residents of Olmsted County, Minnesota, and compare it with the incidence of PDD. DESIGN The medical records linkage system of the Rochester Epidemiology Project was used to identify all persons who developed parkinsonism and, in particular, DLB or PDD from 1991 through 2005 (15 years). A movement disorders specialist reviewed the complete medical records of each suspected patient to confirm the diagnosis. SETTING Olmsted County, Minnesota, from 1991 through 2005 (15 years). PARTICIPANTS All the residents of Olmsted County, Minnesota, who gave authorization for medical record research. MAIN OUTCOMES AND MEASURES Incidence of DLB and PDD. RESULTS Among 542 incident cases of parkinsonism, 64 had DLB and 46 had PDD. The incidence rate of DLB was 3.5 per 100,000 person-years overall, and it increased steeply with age. The incidence of PDD was 2.5 overall and also increased steeply with age. The incidence rate of DLB and PDD combined was 5.9. Patients with DLB were younger at onset of symptoms than patients with PDD and had more hallucinations and cognitive fluctuations. Men had a higher incidence of DLB than women across the age spectrum. The pathology was consistent with the clinical diagnosis in 24 of 31 patients (77.4%) who underwent autopsy. CONCLUSIONS AND RELEVANCE The overall incidence rate of DLB is lower than the rate of Parkinson disease. The incidence of DLB increases steeply with age and is markedly higher in men. This men to women difference may suggest different etiologic mechanisms. Our findings may guide health care planning and prompt new studies.

[1]  W. Rocca,et al.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. , 2013, JAMA neurology.

[2]  Walter A. Rocca,et al.  Risk factors for Parkinson's disease may differ in men and women: an exploratory study , 2013, Hormones and Behavior.

[3]  Scott M. Brue,et al.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. , 2012, International journal of epidemiology.

[4]  B. Yawn,et al.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. , 2012, Mayo Clinic proceedings.

[5]  B. Yawn,et al.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.

[6]  M. S. Luciano,et al.  Gender differences in the risk of familial parkinsonism: Beyond LRRK2? , 2011, Neuroscience Letters.

[7]  Sebastian M. Armasu,et al.  Variants in estrogen‐related genes and risk of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[8]  B. Yawn,et al.  American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .

[9]  J. Dartigues,et al.  A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  Thomas Gasser,et al.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.

[11]  C. Bouras,et al.  Neuropathology of Lewy body disorders , 2009, Brain Research Bulletin.

[12]  L. Melton,et al.  Increased risk of parkinsonism in women who underwent oophorectomy before menopause , 2008, Neurology.

[13]  Kevin R. Sanft,et al.  Chemical exposures and Parkinson's disease: A population‐based case–control study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[14]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[15]  L. Wilkins,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium , 2005 .

[16]  Kevin R. Sanft,et al.  Education and occupations preceding Parkinson disease , 2005, Neurology.

[17]  K. Jellinger Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies , 2004, Neurology.

[18]  P. Zandi,et al.  Incidence of AD may decline in the early 90s for men, later for women , 2002, Neurology.

[19]  E. Mori [Dementia with Lewy bodies]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[20]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[21]  M. Sambrook,et al.  Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[22]  J. Dartigues,et al.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[23]  D. Benson,et al.  Dementia with Lewy bodies , 1996, Neurology.

[24]  K Kosaka,et al.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.

[25]  N. Mantel,et al.  On epidemiologic surveys. , 1983, American journal of epidemiology.

[26]  L. Lipkin,et al.  DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION , 1961, Journal of neuropathology and experimental neurology.

[27]  Joseph E Parisi,et al.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.

[28]  Commission on Professional and Hospital Activities. , 1971, Eye, ear, nose & throat monthly.